VivoSeq
Neurology

Syringomyelia

3

Pipeline Programs↗

3

Active Trials↗

2

Companies Involved↗

Syringomyelia is an early-stage landscape with 3 programs across 2 companies. The most active players are Bristol-Myers Squibb, RECORDATI GROUP.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bristol-Myers Squibb logo

Bristol-Myers Squibb

1 program

Phase 2R

RECORDATI GROUP

1 program

Phase 2

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 23

Thalidomide

Bristol-Myers Squibb

Betaine

RECORDATI GROUP

NC 1 Cell Therapy

Puerta de Hierro University Hospital

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

5

clinical trials

Recruiting2 · 40%
Completed2 · 40%
Active, not recruiting1 · 20%

Clinical Trials

Trial Activity

The Therapeutic Effect of Betaine in Syringomyelia
Recruiting·XXuanwu Hospital, Beijing·Phase 2·NCT06308367·30 enrolled
Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia
Completed·PPuerta de Hierro University Hospital·Phase 2·NCT02807142·6 enrolled
The Therapeutic Effect of Thalidomide in Syringomyelia
Recruiting·XXuanwu Hospital, Beijing·Phase 2·NCT06268093·30 enrolled
Genetic Analysis of the Chiari I Malformation
Completed·National Institute of Neurological Disorders and Stroke (NINDS)·N/A·NCT00004738·152 enrolled
An Exploratory Study on the Use of Intrathecal Injection of Human Autologous Mesenchymal Stromal Cells Derived Extracellular Vesicles for the Treatment of Syringomyelia
Active, not recruiting·XXuanwu Hospital, Beijing·Phase 1·NCT07295067·18 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)